Estrigenix Therapeutics
PrivateLast Round
Seed
Jul 21, 2026
Total Funding Raised
$474,056
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Estrigenix Therapeutics is a biotechnology company developing innovative therapies for menopausal symptoms, including hot flashes and memory dysfunction, by targeting selective estrogen receptor beta.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Estrigenix Therapeutics Comparables
Compare Estrigenix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MenoGeniX, Inc. | 86% | |
| Tioga Pharmaceuticals | 86% | |
| Astellas Pharma Inc. | 77% |
Estrigenix Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 21, 2026 | ||||
| Grant | Jun 19, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | Sep 1, 2022 | ||||
| SAFE | Jun 1, 2022 |
Key People
Founding team and executive leadership
Estrigenix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wisconsin Economic Development Corporation | Grant |
| UWM Research Foundation | Grant |
| Concordia Angel Network | SAFE |
| CU Ventures | Seed |
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 167% MoM, reaching 3K.
- Jul 21, 2026
$2M round led by Talents Fund I
Recent news
Latest coverage and updates
- receives_financingJul 21, 2026
Estrigenix Therapeutics, Inc. received financing of $2M in Seed on Jul 21st '26.
- partners_withJul 8, 2026
Estrigenix Therapeutics, Inc. partnered with Marquette University on Jul 8th '26.
- partners_withJul 8, 2026
Estrigenix Therapeutics, Inc. partnered with Cuventures on Jul 8th '26.
- is_developingJul 8, 2026
Estrigenix Therapeutics, Inc. is developing portfolio of selective estrogen receptor beta small molecules on Jul 8th '26.
Estrigenix Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Estrigenix Therapeutics's valuation, stock price, and market status.
Is Estrigenix Therapeutics a public or private company?
Estrigenix Therapeutics is a private company.
What is the current stock price of Estrigenix Therapeutics?
Estrigenix Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Estrigenix Therapeutics worth (valuation)?
Valuation information for Estrigenix Therapeutics is not publicly available.
Can I buy Estrigenix Therapeutics stock?
Estrigenix Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Estrigenix Therapeutics's last funding round?
Funding round information for Estrigenix Therapeutics is not publicly available.
Who are the main investors in Estrigenix Therapeutics?
Investor information for Estrigenix Therapeutics is not publicly disclosed.
Will Estrigenix Therapeutics IPO soon?
No public IPO plans have been announced for Estrigenix Therapeutics.
How can I track Estrigenix Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Estrigenix Therapeutics's secondary market activity and sign up for updates.